Dx Deals: Labcorp Acquires Stake in European Testing Giant
$152.1 million SYNLAB deal is expected to create a new channel for Labcorp to market its sophisticated specialty assays
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
$152.1 million SYNLAB deal is expected to create a new channel for Labcorp to market its sophisticated specialty assays
Joyce Gresko, partner at Alston & Bird, discusses the latest on PAMA and what will likely need to happen for SALSA to pass in 2024.
UK-developed assay that uses a sponge appears to reduce the need for more invasive endoscopies.
Both companies have made recent moves to diversify further.
These seven strategies can help your small laboratory team overcome challenges to not only succeed, but also thrive.
Tackling recruitment and retention challenges in the clinical laboratory.
Whether the MiniDraw™ device dredges up memories of Theranos’ failed tech remains to be seen.
More aggressive use of artificial intelligence may mitigate issues that lead to the uneven impact of the disease on this group.
Understanding the 2024 CLFS update—and the changes that are still to come.
ASCP chief medical officer Ali Brown, MD, FASCP, discusses the highlights of 2023 and ASCP’s plans for supporting its members in 2024.
Though things appeared status quo in 2023, last year may prove to be a turning point for the laboratory industry.